Business
AbbVie and adMare BioInnovations Announce RIME Therapeutics as AbbVie Biotech Innovators Award Recipient in Quebec
National competition, in collaboration with adMare BioInnovations, demonstrates AbbVie's commitment to a thriving biotech ecosystem in Quebec.Award provides RIME Therapeutics with a year of laboratory and office space, including access to shared equipment and services at the adMare Innovation Centre in Montreal, as well as mentorship from AbbVie’s scientific and business leaders. RIME Therapeutics to impact inflammation and immunology research and innovation. MONTREAL, April 30, 2026 (GLOBE NEWS
About this update from Abbvie Inc.
[{"type":"list","items":[{"val":[{"type":"text","content":"National competition, in collaboration with adMare BioInnovations, demonstrates AbbVie's commitment to a thriving biotech ecosystem in Quebec.","length":146,"tagName":"p"}]},{"val":[{"type":"text","content":"Award provides RIME Therapeutics with a year of laboratory and office space, including access to shared equipment and services at the adMare Innovation Centre in Montreal, as well as mentorship from AbbVie’s scientific and business leaders. ","length":240,"tagName":"p"}]},{"val":[{"type":"text","content":"RIME Therapeutics to impact inflammation and immunology research and innovation.","length":80,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":466,"olType":false},{"type":"text","content":"MONTREAL, April 30, 2026 (GLOBE NEWSWIRE) -- AbbVie (NYSE: ABBV), jointly with adMare BioInnovations, today recognized RIME Therapeutics as the recipient of the AbbVie Biotech Innovators Award, a prize designed to help foster innovation and support growth in Quebec’s life sciences sector.","length":289,"tagName":"p"},{"type":"text","content":"Founded in 2025, RIME Therapeutics is a Montreal-based start-up focused on developing a peptide-based drug discovery platform designed to identify protein-protein interaction targets and accelerate the discovery of therapies for inflammation and immunology. The company impressed the selection committee with its function-first disruptive approach, merging target discovery with simultaneous hit identification, and designed to address novel T cell biology with broad therapeutic applicability.","length":494,"tagName":"p"},{"type":"text","content":"An environment that values innovation is essential to foster growth in Canada’s life sciences sector. Enabling partnerships and offering the right infrastructure, mentorship and collaboration to support early-stage biotech entrepreneurs play a critical role in advancing the next generation of breakthrough therapies for people living with devastating diseases in Canada.","length":371,"tagName":"p"},{"type":"text","content":"The AbbVie Biotech Innovators Award supports early-stage biotechnology companies with the potential to generate transformational therapies in areas that align with AbbVie’s therapeutic areas of focus, including immunology, oncology, neuroscience, and aesthetics. Funded by AbbVie, the award will...